Category - Executive Moves

Executive Moves

Breath Therapeutics names Peter Shadday as chief commercial officer

Closely-held Breath Therapeutics appointed Peter Shadday as chief commercial officer to lead the company’s market access activities and product commercialization.

October 17, 2018

Executive Moves

ContraVir Pharma names biotech industry veteran, Robert Foster, as acting CEO

ContraVir Pharmaceuticals (NASDAQ:CTRV) appointed industry veteran, Robert Foster, as acting CEO, succeeding James Sapirstein.

October 3, 2018

Executive Moves

Imagin Medical names Chris Bleck to its board

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart:DPD2) named Chris Bleck to its board.

October 2, 2018

Executive Moves

Titan Pharma hires commercialization veteran, Dane Hallberg

Titan Pharmaceuticals (NASDAQ:TTNP) appointed Dane Hallberg to the newly created position of EVP and chief commercial officer, effective immediately, with responsibility for leading all of the company’s commercial...

October 2, 2018

Executive Moves

Ondine Biomedical names Cameron Lawrence as COO, CFO

Closely-held Ondine Biomedical appointed Cameron Lawrence as chief operating officer and chief financial officer.

October 1, 2018

Executive Moves

Raymond James names Dane Leone as a managing director in biotech research

Raymond James appointed Dane Leone as a managing director responsible for biotechnology coverage in the firm’s equity research department.

October 1, 2018

Executive Moves

3DS names Sherif Louis as CEO

3D Signatures (TSX:DXD) appointed Sherif Louis, as the company's chief executive officer.

September 25, 2018

Executive Moves

Vincent Gardès joins Truffle Capital’s biomed team as senior partner

Truffle Capital appointed Vincent Gardès to its biomed team as a senior partner, joining Dr. Philippe Pouletty, Alain Chevallier and Antoine Pau.

September 20, 2018

Executive Moves

Shawn Cross joins JMP healthcare investment banking division

JMP Group (NYSE:JMP) named Shawn Cross as a managing director in its healthcare investment-banking group with a focus on the biotechnology and biopharmaceutical sectors.

September 20, 2018

Executive Moves

mdBriefCase names Jason Flowerday as CEO

mdBriefCase, a leading provider of online continuing professional development for physicians, pharmacists, nurses, and other allied healthcare professionals, appointed Jason Flowerday as CEO.

September 17, 2018

Category - Executive Moves

Subscribe